KLK3 and prostate carcinoma: Several studies have reported detection sensitivities of 100% after analyzing circulating sEVs regarding their expression of biomarkers, such as miR-1246 for breast cancer [99] and prostate-specific antigen (PSA) for prostate cancer [100].